Haleon plc (NYSE:HLN) Sees Large Decrease in Short Interest

Haleon plc (NYSE:HLN - Get Free Report) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totalling 19,620,000 shares, a decrease of 13.6% from the April 30th total of 22,720,000 shares. Based on an average daily trading volume, of 14,360,000 shares, the short-interest ratio is currently 1.4 days. Currently, 0.4% of the shares of the stock are sold short.

Analyst Ratings Changes

A number of analysts recently weighed in on HLN shares. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Barclays reaffirmed an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. Wall Street Zen downgraded shares of Haleon from a "buy" rating to a "hold" rating in a report on Thursday, May 22nd. Finally, BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target for the company in a research report on Tuesday, May 27th. Six research analysts have rated the stock with a hold rating, four have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $12.33.

Hedge Funds Weigh In On Haleon

Large investors have recently made changes to their positions in the company. Bartlett & CO. Wealth Management LLC boosted its stake in Haleon by 135.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock valued at $27,000 after purchasing an additional 1,491 shares during the period. Sierra Ocean LLC acquired a new stake in shares of Haleon during the fourth quarter worth $26,000. Banque Transatlantique SA bought a new stake in shares of Haleon in the first quarter valued at about $27,000. Opal Wealth Advisors LLC acquired a new position in shares of Haleon in the first quarter valued at about $29,000. Finally, Ransom Advisory Ltd acquired a new position in shares of Haleon in the first quarter valued at about $31,000. Institutional investors own 6.67% of the company's stock.

Haleon Stock Performance

Shares of HLN stock traded down $0.05 during midday trading on Friday, hitting $11.07. 13,897,070 shares of the company were exchanged, compared to its average volume of 8,708,230. Haleon has a 52 week low of $8.25 and a 52 week high of $11.42. The firm has a market capitalization of $49.84 billion, a P/E ratio of 32.56, a PEG ratio of 2.82 and a beta of 0.31. The firm's 50 day moving average price is $10.48 and its two-hundred day moving average price is $10.02. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.